Disorder of protein N-glycosylation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309347
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of protein N-glycosylation is a group of rare inherited metabolic conditions that affect how the body attaches sugar chains (called glycans) to proteins. This process, known as N-glycosylation, is essential for proteins to work properly throughout the body. When this process is disrupted, it can cause problems in many organs and systems. These disorders are part of a larger family called congenital disorders of glycosylation (CDG). Because glycosylation is needed in nearly every cell, symptoms can be wide-ranging and may include developmental delays, intellectual disability, poor muscle tone, seizures, liver problems, blood clotting issues, and failure to thrive in infancy. Some patients also experience abnormal fat distribution, eye problems, and skeletal abnormalities. The severity varies greatly depending on which specific step in the N-glycosylation pathway is affected. There is currently no cure for most disorders of protein N-glycosylation. Treatment is mainly supportive and focuses on managing individual symptoms. However, for a small number of specific subtypes, targeted therapies such as mannose supplementation (for MPI-CDG) have shown benefit. Early diagnosis and a coordinated care team are important for improving quality of life.

Key symptoms:

Developmental delayIntellectual disabilityPoor muscle tone (floppiness)SeizuresFailure to thrive or poor weight gainLiver problemsBlood clotting abnormalitiesAbnormal fat distribution (fat pads)Crossed eyes or other eye problemsSkeletal abnormalitiesHeart problemsHormonal imbalancesDigestive issues such as diarrhea or vomitingInverted nipplesRecurrent infections

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Disorder of protein N-glycosylation.

View clinical trials →

No actively recruiting trials found for Disorder of protein N-glycosylation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Disorder of protein N-glycosylation community →

No specialists are currently listed for Disorder of protein N-glycosylation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of protein N-glycosylation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of protein N-glycosylationForum →

No community posts yet. Be the first to share your experience with Disorder of protein N-glycosylation.

Start the conversation →

Latest news about Disorder of protein N-glycosylation

No recent news articles for Disorder of protein N-glycosylation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific subtype of CDG does my child have, and what gene is affected?,Are there any targeted treatments available for this specific subtype?,What specialists should be part of our care team, and how often should we see them?,What are the most important warning signs I should watch for at home?,Are there any clinical trials or research studies we could participate in?,What precautions need to be taken before any surgery or dental procedure regarding blood clotting?,What is the expected developmental trajectory, and what therapies can help maximize my child's potential?

Common questions about Disorder of protein N-glycosylation

What is Disorder of protein N-glycosylation?

Disorder of protein N-glycosylation is a group of rare inherited metabolic conditions that affect how the body attaches sugar chains (called glycans) to proteins. This process, known as N-glycosylation, is essential for proteins to work properly throughout the body. When this process is disrupted, it can cause problems in many organs and systems. These disorders are part of a larger family called congenital disorders of glycosylation (CDG). Because glycosylation is needed in nearly every cell, symptoms can be wide-ranging and may include developmental delays, intellectual disability, poor mus